Oro Valley, AZ, United States of America

Linda Anne Pestano

USPTO Granted Patents = 5 



Average Co-Inventor Count = 3.3

ph-index = 4

Forward Citations = 167(Granted Patents)


Company Filing History:


Years Active: 2009-2016

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Linda Anne Pestano

Introduction

Linda Anne Pestano is a prominent inventor based in Oro Valley, Arizona. She has made significant contributions to the field of cancer treatment, particularly through her innovative work involving anti-CD70 antibody-drug conjugates. With a total of five patents to her name, her research has the potential to impact the lives of many patients suffering from various forms of cancer.

Latest Patents

Among her latest patents, Pestano has developed methods for the treatment of renal cell carcinoma using anti-CD70 antibody-drug conjugates. These patents disclose anti-CD70 antibodies and their derivatives, which are conjugated to cytotoxic therapeutic agents. Additionally, she has created pharmaceutical compositions and kits that include these antibody-drug conjugates. Another significant patent focuses on the treatment of B-cell cancers with similar anti-CD70 antibody-drug conjugates, providing further avenues for effective cancer therapies.

Career Highlights

Throughout her career, Linda Anne Pestano has worked with notable companies in the biotechnology sector, including Seattle Genetics, Inc. and Prolx Pharmaceuticals Corporation. Her experience in these organizations has allowed her to refine her expertise in developing innovative cancer treatments.

Collaborations

Pestano has collaborated with esteemed colleagues such as Alan F. Wahl and Nathalie Scholler. These partnerships have contributed to her success in advancing cancer research and developing new therapeutic strategies.

Conclusion

Linda Anne Pestano's work exemplifies the spirit of innovation in the field of cancer treatment. Her patents and collaborations highlight her commitment to improving patient outcomes through groundbreaking research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…